BMP4 inhibits breast cancer metastasis by blocking myeloid-derived suppressor cell activity

Yuan Cao1, Clare Y Slaney1, Bradley N Bidwell1

  • 1Research Division, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia.

Cancer Research
|September 17, 2014
PubMed

Insights

Bone morphogenetic protein 4 (BMP4) suppresses breast cancer metastasis by reducing myeloid-derived suppressor cells (MDSCs). BMP4 inhibits granulocyte colony-stimulating factor (G-CSF) secretion, offering a potential new therapy for breast cancer patients.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Breast cancer metastasis is a major cause of mortality.
  • Myeloid-derived suppressor cells (MDSCs) promote tumor metastasis.
  • Granulocyte colony-stimulating factor (G-CSF) induces MDSCs, enhancing metastasis.

Purpose of the Study:

  • To investigate the role of BMP4 in suppressing breast cancer metastasis.
  • To elucidate the mechanism by which BMP4 affects MDSCs and G-CSF.

Main Methods:

  • Utilized mouse models of mammary tumors.
  • Administered exogenous BMP4 to tumor-bearing mice.
  • Assessed MDSC accumulation and T-cell suppression.
  • Analyzed G-CSF expression and NF-κB activity in tumor cells.

Main Results:

  • Exogenous BMP4 expression reduced MDSC accumulation in metastatic mammary tumors.
  • BMP4 inhibited both tumor-induced and G-CSF-induced MDSCs.
  • BMP4 decreased G-CSF expression and secretion by inhibiting NF-κB activity.
  • MDSCs were found to suppress T-cell activation and proliferation.

Conclusions:

  • BMP4 is a potent suppressor of breast cancer metastasis.
  • BMP4 functions by reducing MDSCs, partly through inhibiting G-CSF secretion via NF-κB.
  • Targeting BMP4 signaling represents a promising therapeutic strategy for breast cancer.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K